Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1999Therapeutic Apheresis and Dialysis

Apheresis and the Thrombotic Thrombocytopenic Purpura Syndrome: Current Advances in Diagnosis, Pathophysiology, and Management

View Full Paper
Ask AI
Bookmark
Share

Authors

LBLisa Louise BraileyUniversity of North Carolina HospitalsMBMark E. BrecherUniversity of North Carolina at Chapel HillNBNicholas BandarenkoUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brailey et al. (1999) studied this question.

synapsesocial.com/papers/6a870c7c48ef9afcd2a25a71https://doi.org/10.1046/j.1526-0968.1999.00143.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange1998 · 160 citations
  2. 2Hazard of Platelet Transfusion in Thrombotic Thrombocytopenic Purpura1981 · 161 citations
  3. 3Plasma exchange with solvent/detergent‐treated plasma of resistant thrombotic thrombocytopenic purpura1996 · 54 citations